Download presentation
Presentation is loading. Please wait.
Published byFerdinand Black Modified over 9 years ago
1
Tracking Scale Up of Maternal and Newborn Health Interventions Jeffrey M. Smith MCHIP Interventions for Impact in Essential Obstetric and Newborn Care Africa Regional Meeting, 21-25 February, 2011
2
Child Mortality: 4 countries in Africa 2 ChadEthiopia Kenya Zambia
3
Maternal Mortality: 4 countries in Africa 3 ChadEthiopia Kenya Zambia
4
Scale up of PPH and PE/E interventions 4 Where are we? And how do we know? How far do we have to go?
5
Awoonor-Williams, et al. HEALTH POLICY AND PLANNING; 20(1): 25–34
6
Conceptual Map for Scale Up Phases of implementation Sequential in logic, not linear in time An attempt to graphically represent the elements of a scale up approach Not exhaustive or able to capture all details 6
7
PATHWAY TO IMPLEMENTATION OF POSTPARTUM HEMORRHAGE PREVENTION AND MANAGEMENT AT SCALE Global Actions National Strategic Choices Program Implementation Sustainability / Institutionalization IntroductionEarlyMature Global advocacy and partnerships: Global action to support work on reduction of PPH Global clinical and program approaches: Evidence-based interventions for prevention and management of PPH demonstrated PPH policy: AMTSL/misoprostol use; Expanded job descriptions for skilled birth attendant cadres managing PPH; PPH service delivery guidelines Health system governance: Proactive financing of maternal health services Drugs & equipment: Oxytocin/ misoprostol procurement, logistics, distribution Service delivery capacity at sites: Reliable infrastructure, personnel, and systems to deliver services Health workers training systems: For PPH prevention and management Community mobilization: Awareness raising of PPH; Birth preparedness Pilot programs: Phase 1 implementation of misoprostol and/or AMTSL for all skilled birth attendant cadres Program initiatives in obstetric and postpartum management: Quality of care; Clinical training; Supervision Pharmaceutical systems: Uterotonics on Essential Drug List and in Drug Registration; Supply chain management National advocacy: Expansion of national program and highlight work of champions Standardization: Quality of care approaches; Government led training expansion Programmatic growth: Adding districts, partners, financing Training programs: Government budgeted training programs on PPH; PPH competencies in pre-service and in- service curricula Clinical coverage: High coverage use of a uterotonic; Public and private implementation Drug & equipment availability: Drugs and supplies in government routine procurement mechanisms REDUCTION OF PPH AND IMPROVED MATERNAL HEALTH STATUS M&E Readiness assessment Pilot project data Survey data Indicators in HMIS Routine monitoring INTRODUCING INNOVATIONMOVING TOWARDS SUSTAINABLE IMPACT AT SCALE Coverage of uterotonic in third stage of labour 0% 25% 50% 75% 100% MCHIP/USAID active programs Other partners active programs Addressed previously, not active No programs
8
PATHWAY TO IMPLEMENTATION OF POSTPARTUM HEMORRHAGE PREVENTION AND MANAGEMENT AT SCALE Global Actions National Strategic Choices Program Implementation Sustainability / Institutionalization IntroductionEarlyMature Global advocacy and partnerships: Global action to support work on reduction of PPH Global clinical and program approaches: Evidence-based interventions for prevention and management of PPH demonstrated PPH policy: AMTSL/misoprostol use; Expanded job descriptions for skilled birth attendant cadres managing PPH; PPH service delivery guidelines Health system governance: Proactive financing of maternal health services Drugs & equipment: Oxytocin/ misoprostol procurement, logistics, distribution Service delivery capacity at sites: Reliable infrastructure, personnel, and systems to deliver services Health workers training systems: For PPH prevention and management Community mobilization: Awareness raising of PPH; Birth preparedness Pilot programs: Phase 1 implementation of misoprostol and/or AMTSL for all skilled birth attendant cadres Program initiatives in obstetric and postpartum management: Quality of care; Clinical training; Supervision Pharmaceutical systems: Uterotonics on Essential Drug List and in Drug Registration; Supply chain management National advocacy: Expansion of national program and highlight work of champions Standardization: Quality of care approaches; Government led training expansion Programmatic growth: Adding districts, partners, financing Training programs: Government budgeted training programs on PPH; PPH competencies in pre-service and in- service curricula Clinical coverage: High coverage use of a uterotonic; Public and private implementation Drug & equipment availability: Drugs and supplies in government routine procurement mechanisms REDUCTION OF PPH AND IMPROVED MATERNAL HEALTH STATUS M&E Readiness assessment Pilot project data Survey data Indicators in HMIS Routine monitoring INTRODUCING INNOVATIONMOVING TOWARDS SUSTAINABLE IMPACT AT SCALE Coverage of uterotonic in third stage of labour 0% 25% 50% 75% 100% MCHIP/USAID active programs Other partners active programs Addressed previously, not active No programs
9
Mapping Scale up Process at National Level Analysis of national/MOH situation Participants and local counterparts Consideration of USAID supported efforts or other partner/donor supported efforts Previous efforts that were fully addressed in the past 9
10
ANGOLA : PATHWAY TO IMPLEMENTATION OF PPH PREVENTION AND MANAGEMENT AT SCALE Global Actions National Strategic Choices Program Implementation Sustainability / Institutionalization IntroductionEarlyMature Global advocacy and partnerships: Global action to support work on reduction of PPH Global clinical and program approaches: Evidence-based interventions for prevention and management of PPH demonstrated PPH policy: AMTSL/misoprostol use; Expanded job descriptions for skilled birth attendant cadres managing PPH; PPH service delivery guidelines Health system governance: Proactive financing of maternal health services Drugs & equipment: Oxytocin/ misoprostol procurement, logistics, distribution Service delivery capacity at sites: Reliable infrastructure, personnel, and systems to deliver services Health workers training systems: For PPH prevention and management Community mobilization: Awareness raising of PPH; Birth preparedness Pilot programs: Phase 1 implementation of misoprostol and/or AMTSL for all skilled birth attendant cadres Program initiatives in obstetric and postpartum management: Quality of care; Clinical training; Supervision Pharmaceutical systems: Uterotonics on Essential Drug List and in Drug Registration; Supply chain management National advocacy: Expansion of national program and highlight work of champions Standardization: Quality of care approaches; Government led training expansion Programmatic growth: Adding districts, partners, financing Training programs: Government budgeted training programs on PPH; PPH competencies in pre-service and in- service curricula Clinical coverage: High coverage use of a uterotonic; Public and private implementation Drug & equipment availability: Drugs and supplies in government routine procurement mechanisms REDUCTION OF PPH AND IMPROVED MATERNAL HEALTH STATUS M&E Readiness assessment Pilot project data Survey data Indicators in HMIS Routine monitoring INTRODUCING INNOVATIONMOVING TOWARDS SUSTAINABLE IMPACT AT SCALE Coverage of uterotonic in third stage of labour 0% 25% 50% 75% 100%
11
MOZAMBIQUE - PATHWAY TO IMPLEMENTATION OF PPH PREVENTION AND MANAGEMENT AT SCALE Global Actions National Strategic Choices Program Implementation Sustainability / Institutionalization IntroductionEarlyMature Global advocacy and partnerships: Global action to support work on reduction of PPH Global clinical and program approaches: Evidence-based interventions for prevention and management of PPH demonstrated PPH policy: AMTSL/misoprostol use; Expanded job descriptions for skilled birth attendant cadres managing PPH; PPH service delivery guidelines Health system governance: Proactive financing of maternal health services Drugs & equipment: Oxytocin/ misoprostol procurement, logistics, distribution Service delivery capacity at sites: Reliable infrastructure, personnel, and systems to deliver services Health workers training systems: For PPH prevention and management Community mobilization: Awareness raising of PPH; Birth preparedness Pilot programs: Phase 1 implementation of misoprostol and/or AMTSL for all skilled birth attendant cadres Program initiatives in obstetric and postpartum management: Quality of care; Clinical training; Supervision Pharmaceutical systems: Uterotonics on Essential Drug List and in Drug Registration; Supply chain management National advocacy: Expansion of national program and highlight work of champions Standardization: Quality of care approaches; Government led training expansion Programmatic growth: Adding districts, partners, financing Training programs: Government budgeted training programs on PPH; PPH competencies in pre-service and in-service curricula Clinical coverage: High coverage use of a uterotonic; Public and private implementation Drug & equipment availability: Drugs and supplies in government routine procurement mechanisms REDUCTION OF PPH AND IMPROVED MATERNAL HEALTH STATUS M&E Readiness assessment Pilot project data Survey data Indicators in HMIS Routine monitoring Introducing innovationMoving toward sustainable impact at scale Coverage of uterotonic in third stage of labour 0% 25% 50% 75% 100%
12
GHANA - PATHWAY TO IMPLEMENTATION OF PPH PREVENTION AND MANAGEMENT AT SCALE Global Actions National Strategic Choices Program Implementation Sustainability / Institutionalization IntroductionEarlyMature Global advocacy and partnerships: Global action to support work on reduction of PPH Global clinical and program approaches: Evidence-based interventions for prevention and management of PPH demonstrated PPH policy: AMTSL/misoprostol use; Expanded job descriptions for skilled birth attendant cadres managing PPH; PPH service delivery guidelines Health system governance: Proactive financing of maternal health services Drugs & equipment: Oxytocin/ misoprostol procurement, logistics, distribution Service delivery capacity at sites: Reliable infrastructure, personnel, and systems to deliver services Health workers training systems: For PPH prevention and management Community mobilization: Awareness raising of PPH; Birth preparedness Pilot programs: Phase 1 implementation of misoprostol and/or AMTSL for all skilled birth attendant cadres Program initiatives in obstetric and postpartum management: Quality of care; Clinical training; Supervision Pharmaceutical systems: Uterotonics on Essential Drug List and in Drug Registration; Supply chain management National advocacy: Expansion of national program and highlight work of champions Standardization: Quality of care approaches; Government led training expansion Programmatic growth: Adding districts, partners, financing Training programs: Government budgeted training programs on PPH; PPH competencies in pre-service and in-service curricula Clinical coverage: High coverage use of a uterotonic; Public and private implementation Drug & equipment availability: Drugs and supplies in government routine procurement mechanisms REDUCTION OF PPH AND IMPROVED MATERNAL HEALTH STATUS M&E Readiness assessment Pilot project data Survey data Indicators in HMIS Routine monitoring INTRODUCING INNOVATIONMOVING TOWARDS SUSTAINABLE IMPACT AT SCALE Coverage of uterotonic in third stage of labour 0% 25% 50% 75% 100% GHS and partners active programing Other partners, with GHS support Addressed previously, not active No programs
13
SOUTH SUDAN - PATHWAY TO IMPLEMENTATION OF PPH PREVENTION AND MANAGEMENT AT SCALE Global Actions National Strategic Choices Program Implementation Sustainability / Institutionalization IntroductionEarlyMature Global advocacy and partnerships: Global action to support work on reduction of PPH Global clinical and program approaches: Evidence-based interventions for prevention and management of PPH demonstrated PPH policy: AMTSL/misoprostol use; Expanded job descriptions for skilled birth attendant cadres managing PPH; PPH service delivery guidelines Health system governance: Proactive financing of maternal health services Drugs & equipment: Oxytocin/ misoprostol procurement, logistics, distribution Service delivery capacity at sites: Reliable infrastructure, personnel, and systems to deliver services Health workers training systems: For PPH prevention and management Community mobilization: Awareness raising of PPH; Birth preparedness Pilot programs: Phase 1 implementation of misoprostol and/or AMTSL for all skilled birth attendant cadres Program initiatives in obstetric and postpartum management: Quality of care; Clinical training; Supervision Pharmaceutical systems: Uterotonics on Essential Drug List and in Drug Registration; Supply chain management National advocacy: Expansion of national program and highlight work of champions Standardization: Quality of care approaches; Government led training expansion Programmatic growth: Adding districts, partners, financing Training programs: Government budgeted training programs on PPH; PPH competencies in pre-service and in- service curricula Clinical coverage: High coverage use of a uterotonic; Public and private implementation Drug & equipment availability: Drugs and supplies in government routine procurement mechanisms REDUCTION OF PPH AND IMPROVED MATERNAL HEALTH STATUS M&E Readiness assessment Pilot project data Survey data Indicators in HMIS Routine monitoring INTRODUCING INNOVATIONMOVING TOWARDS SUSTAINABLE IMPACT AT SCALE Coverage of uterotonic in third stage of labour 0% 25% 50% 75% 100%
14
LIBERIA - PATHWAY TO IMPLEMENTATION OF PPH PREVENTION AND MANAGEMENT AT SCALE Global Actions National Strategic Choices Program Implementation Sustainability / Institutionalization IntroductionEarlyMature Global advocacy and partnerships: Global action to support work on reduction of PPH Global clinical and program approaches: Evidence-based interventions for prevention and management of PPH demonstrated PPH policy: AMTSL/misoprostol use; Expanded job descriptions for skilled birth attendant cadres managing PPH; PPH service delivery guidelines Health system governance: Proactive financing of maternal health services Drugs & equipment: Oxytocin/ misoprostol procurement, logistics, distribution Service delivery capacity at sites: Reliable infrastructure, personnel, and systems to deliver services Health workers training systems: For PPH prevention and management Community mobilization: Awareness raising of PPH; Birth preparedness Pilot programs: Phase 1 implementation of misoprostol and/or AMTSL for all skilled birth attendant cadres Program initiatives in obstetric and postpartum management: Quality of care; Clinical training; Supervision Pharmaceutical systems: Uterotonics on Essential Drug List and in Drug Registration; Supply chain management National advocacy: Expansion of national program and highlight work of champions Standardization: Quality of care approaches; Government led training expansion Programmatic growth: Adding districts, partners, financing Training programs: Government budgeted training programs on PPH; PPH competencies in pre-service and in-service curricula Clinical coverage: High coverage use of a uterotonic; Public and private implementation Drug & equipment availability: Drugs and supplies in government routine procurement mechanisms REDUCTION OF PPH AND IMPROVED MATERNAL HEALTH STATUS M&E Readiness assessment Pilot project data Survey data Indicators in HMIS Routine monitoring INTRODUCING INNOVATIONMOVING TOWARDS SUSTAINABLE IMPACT AT SCALE Coverage of uterotonic in third stage of labour 0% 25% 50% 75% 100%
15
ETHIOPIA : PATHWAY TO IMPLEMENTATION OF PPH PREVENTION AND MANAGEMENT AT SCALE Global Actions National Strategic Choices Program Implementation Sustainability / Institutionalization IntroductionEarlyMature Global advocacy and partnerships: Global action to support work on reduction of PPH Global clinical and program approaches: Evidence-based interventions for prevention and management of PPH demonstrated PPH policy: AMTSL/misoprostol use; Expanded job descriptions for skilled birth attendant cadres managing PPH; PPH service delivery guidelines Health system governance: Proactive financing of maternal health services Drugs & equipment: Oxytocin/ misoprostol procurement, logistics, distribution Service delivery capacity at sites: Reliable infrastructure, personnel, and systems to deliver services Health workers training systems: For PPH prevention and management Community mobilization: Awareness raising of PPH; Birth preparedness Pilot programs: Phase 1 implementation of misoprostol and/or AMTSL for all skilled birth attendant cadres Program initiatives in obstetric and postpartum management: Quality of care; Clinical training; Supervision Pharmaceutical systems: Uterotonics on Essential Drug List and in Drug Registration; Supply chain management National advocacy: Expansion of national program and highlight work of champions Standardization: Quality of care approaches; Government led training expansion Programmatic growth: Adding districts, partners, financing Training programs: Government budgeted training programs on PPH; PPH competencies in pre-service and in-service curricula Clinical coverage: High coverage use of a uterotonic; Public and private implementation Drug & equipment availability: Drugs and supplies in government routine procurement mechanisms REDUCTION OF PPH AND IMPROVED MATERNAL HEALTH STATUS M&E Readiness assessment Pilot project data Survey data Indicators in HMIS Routine monitoring INTRODUCING INNOVATIONMOVING TOWARDS SUSTAINABLE IMPACT AT SCALE Coverage of uterotonic in third stage of labour 0% 25% 50% 75% 100%
16
MADAGASCAR - PATHWAY TO IMPLEMENTATION OF PPH PREVENTION AND MANAGEMENT AT SCALE Global Actions National Strategic Choices Program Implementation Sustainability / Institutionalization IntroductionEarlyMature Global advocacy and partnerships: Global action to support work on reduction of PPH Global clinical and program approaches: Evidence-based interventions for prevention and management of PPH demonstrated PPH policy: AMTSL/misoprostol use; Expanded job descriptions for skilled birth attendant cadres managing PPH; PPH service delivery guidelines Health system governance: Proactive financing of maternal health services Drugs & equipment: Oxytocin/ misoprostol procurement, logistics, distribution Service delivery capacity at sites: Reliable infrastructure, personnel, and systems to deliver services Health workers training systems: For PPH prevention and management Community mobilization: Awareness raising of PPH; Birth preparedness Pilot programs: Phase 1 implementation of misoprostol and/or AMTSL for all skilled birth attendant cadres Program initiatives in obstetric and postpartum management: Quality of care; Clinical training; Supervision Pharmaceutical systems: Uterotonics on Essential Drug List and in Drug Registration; Supply chain management National advocacy: Expansion of national program and highlight work of champions Standardization: Quality of care approaches; Government led training expansion Programmatic growth: Adding districts, partners, financing Training programs: Government budgeted training programs on PPH; PPH competencies in pre-service and in-service curricula Clinical coverage: High coverage use of a uterotonic; Public and private implementation Drug & equipment availability: Drugs and supplies in government routine procurement mechanisms REDUCTION OF PPH AND IMPROVED MATERNAL HEALTH STATUS M&E Readiness assessment Pilot project data Survey data Indicators in HMIS Routine monitoring INTRODUCING INNOVATIONMOVING TOWARDS SUSTAINABLE IMPACT AT SCALE Coverage of uterotonic in third stage of labour 0% 25% 50% 75% 100%
17
MALAWI - PATHWAY TO IMPLEMENTATION OF PPH PREVENTION AND MANAGEMENT AT SCALE Global Actions National Strategic Choices Program Implementation Sustainability / Institutionalization IntroductionEarlyMature Global advocacy and partnerships: Global action to support work on reduction of PPH Global clinical and program approaches: Evidence-based interventions for prevention and management of PPH demonstrated PPH policy: AMTSL/misoprostol use; Expanded job descriptions for skilled birth attendant cadres managing PPH; PPH service delivery guidelines Health system governance: Proactive financing of maternal health services Drugs & equipment: Oxytocin/ misoprostol procurement, logistics, distribution Service delivery capacity at sites: Reliable infrastructure, personnel, and systems to deliver services Health workers training systems: For PPH prevention and management Community mobilization: Awareness raising of PPH; Birth preparedness Pilot programs: Phase 1 implementation of misoprostol and/or AMTSL for all skilled birth attendant cadres Program initiatives in obstetric and postpartum management: Quality of care; Clinical training; Supervision Pharmaceutical systems: Uterotonics on Essential Drug List and in Drug Registration; Supply chain management National advocacy: Expansion of national program and highlight work of champions Standardization: Quality of care approaches; Government led training expansion Programmatic growth: Adding districts, partners, financing Training programs: Government budgeted training programs on PPH; PPH competencies in pre-service and in-service curricula Clinical coverage: High coverage use of a uterotonic; Public and private implementation Drug & equipment availability: Drugs and supplies in government routine procurement mechanisms REDUCTION OF PPH AND IMPROVED MATERNAL HEALTH STATUS M&E Readiness assessment Pilot project data Survey data Indicators in HMIS Routine monitoring INTRODUCING INNOVATIONMOVING TOWARDS SUSTAINABLE IMPACT AT SCALE Coverage of uterotonic in third stage of labour 0% 25% 50% 75% 100%
18
NIGERIA : PATHWAY TO IMPLEMENTATION OF PPH PREVENTION AND MANAGEMENT AT SCALE Global Actions National Strategic Choices Program Implementation Sustainability / Institutionalization IntroductionEarlyMature Global advocacy and partnerships: Global action to support work on reduction of PPH Global clinical and program approaches: Evidence-based interventions for prevention and management of PPH demonstrated PPH policy: AMTSL/misoprostol use; Expanded job descriptions for skilled birth attendant cadres managing PPH; PPH service delivery guidelines Health system governance: Proactive financing of maternal health services Drugs & equipment: Oxytocin/ misoprostol procurement, logistics, distribution Service delivery capacity at sites: Reliable infrastructure, personnel, and systems to deliver services Health workers training systems: For PPH prevention and management Community mobilization: Awareness raising of PPH; Birth preparedness Pilot programs: Phase 1 implementation of misoprostol and/or AMTSL for all skilled birth attendant cadres Program initiatives in obstetric and postpartum management: Quality of care; Clinical training; Supervision Pharmaceutical systems: Uterotonics on Essential Drug List and in Drug Registration; Supply chain management National advocacy: Expansion of national program and highlight work of champions Standardization: Quality of care approaches; Government led training expansion Programmatic growth: Adding districts, partners, financing Training programs: Government budgeted training programs on PPH; PPH competencies in pre-service and in-service curricula Clinical coverage: High coverage use of a uterotonic; Public and private implementation Drug & equipment availability: Drugs and supplies in government routine procurement mechanisms REDUCTION OF PPH AND IMPROVED MATERNAL HEALTH STATUS M&E Readiness assessment Pilot project data Survey data Indicators in HMIS Routine monitoring INTRODUCING INNOVATIONMOVING TOWARDS SUSTAINABLE IMPACT AT SCALE Coverage of uterotonic in third stage of labour 0% 25% 50% 75% 100%
19
RWANDA - PATHWAY TO IMPLEMENTATION OF PPH PREVENTION AND MANAGEMENT AT SCALE Global Actions National Strategic Choices Program Implementation Sustainability / Institutionalization IntroductionEarlyMature Global advocacy and partnerships: Global action to support work on reduction of PPH Global clinical and program approaches: Evidence-based interventions for prevention and management of PPH demonstrated PPH policy: AMTSL/misoprostol use; Expanded job descriptions for skilled birth attendant cadres managing PPH; PPH service delivery guidelines Health system governance: Proactive financing of maternal health services Drugs & equipment: Oxytocin/ misoprostol procurement, logistics, distribution Service delivery capacity at sites: Reliable infrastructure, personnel, and systems to deliver services Health workers training systems: For PPH prevention and management Community mobilization: Awareness raising of PPH; Birth preparedness Pilot programs: Phase 1 implementation of misoprostol and/or AMTSL for all skilled birth attendant cadres Program initiatives in obstetric and postpartum management: Quality of care; Clinical training; Supervision Pharmaceutical systems: Uterotonics on Essential Drug List and in Drug Registration; Supply chain management National advocacy: Expansion of national program and highlight work of champions Standardization: Quality of care approaches; Government led training expansion Programmatic growth: Adding districts, partners, financing Training programs: Government budgeted training programs on PPH; PPH competencies in pre-service and in-service curricula Clinical coverage: High coverage use of a uterotonic; Public and private implementation Drug & equipment availability: Drugs and supplies in government routine procurement mechanisms REDUCTION OF PPH AND IMPROVED MATERNAL HEALTH STATUS M&E Readiness assessment Pilot project data Survey data Indicators in HMIS Routine monitoring INTRODUCING INNOVATIONMOVING TOWARDS SUSTAINABLE IMPACT AT SCALE Coverage of uterotonic in third stage of labour 0% 25% 50% 75% 100%
20
SENEGAL: PATHWAY TO IMPLEMENTATION OF PPH PREVENTION AND MANAGEMENT AT SCALE Global Actions National Strategic Choices Program Implementation Sustainability / Institutionalization IntroductionEarlyMature Global advocacy and partnerships: Global action to support work on reduction of PPH Global clinical and program approaches: Evidence-based interventions for prevention and management of PPH demonstrated PPH policy: AMTSL/misoprostol use; Expanded job descriptions for skilled birth attendant cadres managing PPH; PPH service delivery guidelines Health system governance: Proactive financing of maternal health services Drugs & equipment: Oxytocin/procureme nt, logistics, distribution Service delivery capacity at sites: Reliable infrastructure, personnel, and systems to deliver services Health workers training systems: For PPH prevention and management Community mobilization: Awareness raising of PPH; Birth preparedness Pilot programs: Phase 1 implementation AMTSL for all skilled birth attendant cadres Program initiatives in obstetric and postpartum management: Quality of care; Clinical training; Supervision Pharmaceutical systems: Uterotonics on Essential Drug List and in Drug Registration; Supply chain management National advocacy: Expansion of national program and highlight work of champions Standardization: Quality of care approaches; Government led training expansion Programmatic growth: Adding districts, partners, financing Training programs: Government budgeted training programs on PPH; PPH competencies in pre-service and in-service curricula Clinical coverage: High coverage use of a uterotonic; Public and private implementation Drug & equipment availability: Drugs and supplies in government routine procurement mechanisms REDUCTION OF PPH AND IMPROVED MATERNAL HEALTH STATUS M&E Readiness assessment Pilot project data Survey data Indicators in HMIS Routine monitoring INTRODUCING INNOVATIONMOVING TOWARDS SUSTAINABLE IMPACT AT SCALE Coverage of uterotonic in third stage of labour 0% 25% 50% 75% 100% MCHIP/USAID active programs Other partners active programs Addressed previously, not active No programs 81%
21
UGANDA : PATHWAY TO IMPLEMENTATION OF PPH PREVENTION AND MANAGEMENT AT SCALE Global Actions National Strategic Choices Program Implementation Sustainability / Institutionalization IntroductionEarlyMature Global advocacy and partnerships: Global action to support work on reduction of PPH Global clinical and program approaches: Evidence-based interventions for prevention and management of PPH demonstrated PPH policy: AMTSL/misoprostol use; Expanded job descriptions for skilled birth attendant cadres managing PPH; PPH service delivery guidelines Health system governance: Proactive financing of maternal health services Drugs & equipment: Oxytocin/ misoprostol procurement, logistics, distribution Service delivery capacity at sites: Reliable infrastructure, personnel, and systems to deliver services Health workers training systems: For PPH prevention and management Community mobilization: Awareness raising of PPH; Birth preparedness Pilot programs: Phase 1 implementation of misoprostol and/or AMTSL for all skilled birth attendant cadres Program initiatives in obstetric and postpartum management: Quality of care; Clinical training; Supervision Pharmaceutical systems: Uterotonics on Essential Drug List and in Drug Registration; Supply chain management National advocacy: Expansion of national program and highlight work of champions Standardization: Quality of care approaches; Government led training expansion Programmatic growth: Adding districts, partners, financing Training programs: Government budgeted training programs on PPH; PPH competencies in pre-service and in-service curricula Clinical coverage: High coverage use of a uterotonic; Public and private implementation Drug & equipment availability: Drugs and supplies in government routine procurement mechanisms REDUCTION OF PPH AND IMPROVED MATERNAL HEALTH STATUS M&E Readiness assessment Pilot project data Survey data Indicators in HMIS Routine monitoring INTRODUCING INNOVATIONMOVING TOWARDS SUSTAINABLE IMPACT AT SCALE Coverage of uterotonic in third stage of labour 0% 25% 50% 75% 100%
22
ZAMBIA : PATHWAY TO IMPLEMENTATION OF PPH PREVENTION AND MANAGEMENT AT SCALE Global Actions National Strategic Choices Program Implementation Sustainability / Institutionalization IntroductionEarlyMature Global advocacy and partnerships: Global action to support work on reduction of PPH Global clinical and program approaches: Evidence-based interventions for prevention and management of PPH demonstrated PPH policy: AMTSL/misoprostol use; Expanded job descriptions for skilled birth attendant cadres managing PPH; PPH service delivery guidelines Health system governance: Proactive financing of maternal health services Drugs & equipment: Oxytocin/ misoprostol procurement, logistics, distribution Service delivery capacity at sites: Reliable infrastructure, personnel, and systems to deliver services Health workers training systems: For PPH prevention and management Community mobilization: Awareness raising of PPH; Birth preparedness Pilot programs: Phase 1 implementation of misoprostol and/or AMTSL for all skilled birth attendant cadres Program initiatives in obstetric and postpartum management: Quality of care; Clinical training; Supervision Pharmaceutical systems: Uterotonics on Essential Drug List and in Drug Registration; Supply chain management National advocacy: Expansion of national program and highlight work of champions Standardization: Quality of care approaches; Government led training expansion Programmatic growth: Adding districts, partners, financing Training programs: Government budgeted training programs on PPH; PPH competencies in pre-service and in-service curricula Clinical coverage: High coverage use of a uterotonic; Public and private implementation Drug & equipment availability: Drugs and supplies in government routine procurement mechanisms REDUCTION OF PPH AND IMPROVED MATERNAL HEALTH STATUS M&E Readiness assessment Pilot project data Survey data Indicators in HMIS Routine monitoring INTRODUCING INNOVATIONMOVING TOWARDS SUSTAINABLE IMPACT AT SCALE Coverage of uterotonic in third stage of labour 0% 25% 50% 75% 100%
23
ZIMBABWE : PATHWAY TO IMPLEMENTATION OF PPH PREVENTION AND MANAGEMENT AT SCALE Global Actions National Strategic Choices Program Implementation Sustainability / Institutionalization IntroductionEarlyMature Global advocacy and partnerships: Global action to support work on reduction of PPH Global clinical and program approaches: Evidence-based interventions for prevention and management of PPH demonstrated PPH policy: AMTSL/misoprostol use; Expanded job descriptions for skilled birth attendant cadres managing PPH; PPH service delivery guidelines Health system governance: Proactive financing of maternal health services Drugs & equipment: Oxytocin/ misoprostol procurement, logistics, distribution Service delivery capacity at sites: Reliable infrastructure, personnel, and systems to deliver services Health workers training systems: For PPH prevention and management Community mobilization: Awareness raising of PPH; Birth preparedness Pilot programs: Phase 1 implementation of misoprostol and/or AMTSL for all skilled birth attendant cadres Program initiatives in obstetric and postpartum management: Quality of care; Clinical training; Supervision Pharmaceutical systems: Uterotonics on Essential Drug List and in Drug Registration; Supply chain management National advocacy: Expansion of national program and highlight work of champions Standardization: Quality of care approaches; Government led training expansion Programmatic growth: Adding districts, partners, financing Training programs: Government budgeted training programs on PPH; PPH competencies in pre-service and in-service curricula Clinical coverage: High coverage use of a uterotonic; Public and private implementation Drug & equipment availability: Drugs and supplies in government routine procurement mechanisms REDUCTION OF PPH AND IMPROVED MATERNAL HEALTH STATUS M&E Readiness assessment Pilot project data Survey data Indicators in HMIS Routine monitoring INTRODUCING INNOVATIONMOVING TOWARDS SUSTAINABLE IMPACT AT SCALE Coverage of uterotonic in third stage of labour 0% 25% 50% 75% 100%
24
National Maps of Scale up Process Tracking progress over time Platform for national and international conversation about progress Identifying gaps and securing additional support / resources. Please view the posters in the corridor!! 24
25
Thank you! wwww.mchip.net Follow us on:
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.